Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cameron L. Calloway"'
Autor:
Bethany N. Hannafon, Angela Cai, Cameron L. Calloway, Yi-Fan Xu, Roy Zhang, Kar-Ming Fung, Wei-Qun Ding
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Altered expression of microRNAs (miRNAs) is known to contribute to cancer progression. miR-23b and miR-27b, encoded within the same miRNA cluster, are reported to have both tumor suppressive and oncogenic activity across human can
Externí odkaz:
https://doaj.org/article/1bda0b8a0f424485aee03fc8a7a2d00b
Publikováno v:
Cell Communication and Signaling, Vol 17, Iss 1, Pp 1-13 (2019)
Abstract Background Exosomes are small membrane-bound vesicles that contribute to tumor progression and metastasis by mediating cell-to-cell communication and modifying the tumor microenvironment at both local and distant sites. However, little is kn
Externí odkaz:
https://doaj.org/article/945bf7a95ade47a6883de1b6e2e619b1
Autor:
Kar Ming Fung, Roy Zhang, Angela Cai, Yifan Xu, Cameron L. Calloway, Bethany N. Hannafon, Wei Qun Ding
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
BMC Cancer
BMC Cancer
Background Altered expression of microRNAs (miRNAs) is known to contribute to cancer progression. miR-23b and miR-27b, encoded within the same miRNA cluster, are reported to have both tumor suppressive and oncogenic activity across human cancers, inc
Publikováno v:
Cell Communication and Signaling : CCS
Cell Communication and Signaling, Vol 17, Iss 1, Pp 1-13 (2019)
Cell Communication and Signaling, Vol 17, Iss 1, Pp 1-13 (2019)
Background Exosomes are small membrane-bound vesicles that contribute to tumor progression and metastasis by mediating cell-to-cell communication and modifying the tumor microenvironment at both local and distant sites. However, little is known about
Autor:
Kenneth E. Blick, Alana L. Welm, Y. Daniel Zhao, Cameron L. Calloway, Zhizhuang Joe Zhao, David H. Lum, William C. Dooley, Bethany N. Hannafon, Wei Qun Ding, Yvonne D. Trigoso
Publikováno v:
Breast Cancer Research : BCR
Background microRNAs are promising candidate breast cancer biomarkers due to their cancer-specific expression profiles. However, efforts to develop circulating breast cancer biomarkers are challenged by the heterogeneity of microRNAs in the blood. To